Combivent, a metered-dose inhaler that combines two different bronchodilators
Boehringer Ingelheim will soon market Combivent, a metered-dose inhaler that combines two different bronchodilators...the anticholinergic, ipratropium (Atrovent)...and the beta-agonist, albuterol (Ventolin, etc).
Combivent is for chronic obstructive pulmonary disease (COPD). It'll be used as SECOND-LINE therapy...for patients who don't do well on either bronchodilator alone.
Don't use Combivent for chronic asthma...there's no benefit from adding ipratropium to inhaled beta-agonists in asthmatics.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote